GAUDIUMIVF Gaudium IVF and Women Health Q1 FY27 results (Apr–Jun 2026) and concall
Gaudium IVF and Women Health Limited reported a 9.1% YoY revenue growth to ₹19.4 crores in Q1 FY27. However, profitability metrics like EBITDA and PAT saw significant moderation due to strategic investments in new AI technology and pre-operational costs for new centers. The company remains confident in its full-year targets, driven by its expansion roadmap, clinical excellence, and debt-light balance sheet.
You’re reading a preview. Opening the full call uses 1 concall credit.
Sign in to use your monthly call allowance.
What they filed
Q1 FY27: revenue up 9.1%, net profit down 42.0% against the same quarter last year.
| Line item | Q3 FY25 | Q4 FY25 | Q1 FY26 | Q2 FY26 | Q3 FY26 | Q4 FY26 | Q1 FY27 |
|---|---|---|---|---|---|---|---|
| Revenue | 14 | 27 | 18 | 32 | 25 +70% | 30 +13% | 19 +9% |
| EBITDA | 6 | 9 | 5 | 14 | 7 +16% | 12 +40% | 2 −53% |
| Net profit | 3 | 6 | 3 | 9 | 4 +7% | 8 +29% | 2 −42% |
How to read this
₹ crore, as filed. The percentage beside a figure is the change against the same quarter a year earlier — never the quarter before, which would make every seasonal business look like it collapses and booms each year.
Inve summary of a publicly available earnings call transcript; see how call summaries are prepared. Not investment advice.
